|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/5575 | |||
| A61K 47/36 | |||
| A61K 47/02 | |||
| A61K 31/5377 | |||
| A61K 31/728 | |||
| A61P 27/06 |
| (11) | Number of the document | 2763654 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12759652.6 |
| Date of filing the European patent application | 2012-09-11 | |
| (97) | Date of publication of the European application | 2014-08-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/003810 |
| Date | 2012-09-11 |
| (87) | Number | WO 2013/037479 |
| Date | 2013-03-21 |
| (30) | Number | Date | Country code |
| 11306137 | 2011-09-12 | EP |
| (72) |
HADJ-SLIMANE, Réda, FR
|
| (73) |
Unither Pharmaceuticals,
151 rue André Durouchez CS 28028, 80084 Amiens Cedex 2,
FR
|
| (54) | OPHTHTALMIC COMPOSITIONS COMPRISING PROSTAGLANDIN F2 ALPHA DERIVATIVES AND HYALURONIC ACID |
| OPHTHTALMIC COMPOSITIONS COMPRISING PROSTAGLANDIN F2 ALPHA DERIVATIVES AND HYALURONIC ACID |